1 Hip Osteoarthritis Pain Medicine Market Overview 1.1 Product Overview and Scope of Hip Osteoarthritis Pain Medicine 1.2 Hip Osteoarthritis Pain Medicine Segment by Type 1.2.1 Global Hip Osteoarthritis Pain Medicine Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Oral 1.2.3 Injection 1.2.4 External 1.3 Hip Osteoarthritis Pain Medicine Segment by Application 1.3.1 Global Hip Osteoarthritis Pain Medicine Sales Comparison by Application: (2021-2027) 1.3.2 Medical Care 1.3.3 Personal Care 1.4 Global Hip Osteoarthritis Pain Medicine Market Size Estimates and Forecasts 1.4.1 Global Hip Osteoarthritis Pain Medicine Revenue 2016-2027 1.4.2 Global Hip Osteoarthritis Pain Medicine Sales 2016-2027 1.4.3 Hip Osteoarthritis Pain Medicine Market Size by Region: 2016 Versus 2021 Versus 2027 2 Hip Osteoarthritis Pain Medicine Market Competition by Manufacturers 2.1 Global Hip Osteoarthritis Pain Medicine Sales Market Share by Manufacturers (2016-2021) 2.2 Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Hip Osteoarthritis Pain Medicine Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Hip Osteoarthritis Pain Medicine Manufacturing Sites, Area Served, Product Type 2.5 Hip Osteoarthritis Pain Medicine Market Competitive Situation and Trends 2.5.1 Hip Osteoarthritis Pain Medicine Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Hip Osteoarthritis Pain Medicine Players Market Share by Revenue 2.5.3 Global Hip Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Hip Osteoarthritis Pain Medicine Retrospective Market Scenario by Region 3.1 Global Hip Osteoarthritis Pain Medicine Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Hip Osteoarthritis Pain Medicine Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Hip Osteoarthritis Pain Medicine Market Facts & Figures by Country 3.3.1 North America Hip Osteoarthritis Pain Medicine Sales by Country 3.3.2 North America Hip Osteoarthritis Pain Medicine Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Hip Osteoarthritis Pain Medicine Market Facts & Figures by Country 3.4.1 Europe Hip Osteoarthritis Pain Medicine Sales by Country 3.4.2 Europe Hip Osteoarthritis Pain Medicine Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Hip Osteoarthritis Pain Medicine Market Facts & Figures by Region 3.5.1 Asia Pacific Hip Osteoarthritis Pain Medicine Sales by Region 3.5.2 Asia Pacific Hip Osteoarthritis Pain Medicine Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Hip Osteoarthritis Pain Medicine Market Facts & Figures by Country 3.6.1 Latin America Hip Osteoarthritis Pain Medicine Sales by Country 3.6.2 Latin America Hip Osteoarthritis Pain Medicine Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Hip Osteoarthritis Pain Medicine Market Facts & Figures by Country 3.7.1 Middle East and Africa Hip Osteoarthritis Pain Medicine Sales by Country 3.7.2 Middle East and Africa Hip Osteoarthritis Pain Medicine Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Hip Osteoarthritis Pain Medicine Historic Market Analysis by Type 4.1 Global Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2016-2021) 4.2 Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Type (2016-2021) 4.3 Global Hip Osteoarthritis Pain Medicine Price by Type (2016-2021) 5 Global Hip Osteoarthritis Pain Medicine Historic Market Analysis by Application 5.1 Global Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2016-2021) 5.2 Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Application (2016-2021) 5.3 Global Hip Osteoarthritis Pain Medicine Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Pfizer Hip Osteoarthritis Pain Medicine Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 Johnson and Johnson 6.2.1 Johnson and Johnson Corporation Information 6.2.2 Johnson and Johnson Description and Business Overview 6.2.3 Johnson and Johnson Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Johnson and Johnson Hip Osteoarthritis Pain Medicine Product Portfolio 6.2.5 Johnson and Johnson Recent Developments/Updates 6.3 GlaxoSmithKline 6.3.1 GlaxoSmithKline Corporation Information 6.3.2 GlaxoSmithKline Description and Business Overview 6.3.3 GlaxoSmithKline Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.3.4 GlaxoSmithKline Hip Osteoarthritis Pain Medicine Product Portfolio 6.3.5 GlaxoSmithKline Recent Developments/Updates 6.4 Bayer 6.4.1 Bayer Corporation Information 6.4.2 Bayer Description and Business Overview 6.4.3 Bayer Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Bayer Hip Osteoarthritis Pain Medicine Product Portfolio 6.4.5 Bayer Recent Developments/Updates 6.5 Eli Lilly 6.5.1 Eli Lilly Corporation Information 6.5.2 Eli Lilly Description and Business Overview 6.5.3 Eli Lilly Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Eli Lilly Hip Osteoarthritis Pain Medicine Product Portfolio 6.5.5 Eli Lilly Recent Developments/Updates 6.6 Novartis 6.6.1 Novartis Corporation Information 6.6.2 Novartis Description and Business Overview 6.6.3 Novartis Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Novartis Hip Osteoarthritis Pain Medicine Product Portfolio 6.6.5 Novartis Recent Developments/Updates 6.7 Sanofi 6.6.1 Sanofi Corporation Information 6.6.2 Sanofi Description and Business Overview 6.6.3 Sanofi Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Sanofi Hip Osteoarthritis Pain Medicine Product Portfolio 6.7.5 Sanofi Recent Developments/Updates 6.8 Horizon Pharma 6.8.1 Horizon Pharma Corporation Information 6.8.2 Horizon Pharma Description and Business Overview 6.8.3 Horizon Pharma Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Horizon Pharma Hip Osteoarthritis Pain Medicine Product Portfolio 6.8.5 Horizon Pharma Recent Developments/Updates 6.9 Abbott 6.9.1 Abbott Corporation Information 6.9.2 Abbott Description and Business Overview 6.9.3 Abbott Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Abbott Hip Osteoarthritis Pain Medicine Product Portfolio 6.9.5 Abbott Recent Developments/Updates 6.10 Mylan 6.10.1 Mylan Corporation Information 6.10.2 Mylan Description and Business Overview 6.10.3 Mylan Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Mylan Hip Osteoarthritis Pain Medicine Product Portfolio 6.10.5 Mylan Recent Developments/Updates 6.11 Daiichi Sankyo 6.11.1 Daiichi Sankyo Corporation Information 6.11.2 Daiichi Sankyo Hip Osteoarthritis Pain Medicine Description and Business Overview 6.11.3 Daiichi Sankyo Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Daiichi Sankyo Hip Osteoarthritis Pain Medicine Product Portfolio 6.11.5 Daiichi Sankyo Recent Developments/Updates 6.12 TEVA 6.12.1 TEVA Corporation Information 6.12.2 TEVA Hip Osteoarthritis Pain Medicine Description and Business Overview 6.12.3 TEVA Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.12.4 TEVA Hip Osteoarthritis Pain Medicine Product Portfolio 6.12.5 TEVA Recent Developments/Updates 6.13 Almatica Pharma 6.13.1 Almatica Pharma Corporation Information 6.13.2 Almatica Pharma Hip Osteoarthritis Pain Medicine Description and Business Overview 6.13.3 Almatica Pharma Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Almatica Pharma Hip Osteoarthritis Pain Medicine Product Portfolio 6.13.5 Almatica Pharma Recent Developments/Updates 6.14 Astellas Pharma 6.14.1 Astellas Pharma Corporation Information 6.14.2 Astellas Pharma Hip Osteoarthritis Pain Medicine Description and Business Overview 6.14.3 Astellas Pharma Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Astellas Pharma Hip Osteoarthritis Pain Medicine Product Portfolio 6.14.5 Astellas Pharma Recent Developments/Updates 6.15 Tide Pharmaceutical 6.15.1 Tide Pharmaceutical Corporation Information 6.15.2 Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Description and Business Overview 6.15.3 Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Product Portfolio 6.15.5 Tide Pharmaceutical Recent Developments/Updates 6.16 Iroko Pharmaceuticals 6.16.1 Iroko Pharmaceuticals Corporation Information 6.16.2 Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Description and Business Overview 6.16.3 Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.16.4 Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Product Portfolio 6.16.5 Iroko Pharmaceuticals Recent Developments/Updates 6.17 Hengrui Pharmaceutical 6.17.1 Hengrui Pharmaceutical Corporation Information 6.17.2 Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Description and Business Overview 6.17.3 Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.17.4 Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Product Portfolio 6.17.5 Hengrui Pharmaceutical Recent Developments/Updates 6.18 Abiogen Pharma 6.18.1 Abiogen Pharma Corporation Information 6.18.2 Abiogen Pharma Hip Osteoarthritis Pain Medicine Description and Business Overview 6.18.3 Abiogen Pharma Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2016-2021) 6.18.4 Abiogen Pharma Hip Osteoarthritis Pain Medicine Product Portfolio 6.18.5 Abiogen Pharma Recent Developments/Updates 7 Hip Osteoarthritis Pain Medicine Manufacturing Cost Analysis 7.1 Hip Osteoarthritis Pain Medicine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Hip Osteoarthritis Pain Medicine 7.4 Hip Osteoarthritis Pain Medicine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Hip Osteoarthritis Pain Medicine Distributors List 8.3 Hip Osteoarthritis Pain Medicine Customers 9 Hip Osteoarthritis Pain Medicine Market Dynamics 9.1 Hip Osteoarthritis Pain Medicine Industry Trends 9.2 Hip Osteoarthritis Pain Medicine Growth Drivers 9.3 Hip Osteoarthritis Pain Medicine Market Challenges 9.4 Hip Osteoarthritis Pain Medicine Market Restraints 10 Global Market Forecast 10.1 Hip Osteoarthritis Pain Medicine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Hip Osteoarthritis Pain Medicine by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Hip Osteoarthritis Pain Medicine by Type (2022-2027) 10.2 Hip Osteoarthritis Pain Medicine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Hip Osteoarthritis Pain Medicine by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Hip Osteoarthritis Pain Medicine by Application (2022-2027) 10.3 Hip Osteoarthritis Pain Medicine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Hip Osteoarthritis Pain Medicine by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Hip Osteoarthritis Pain Medicine by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Hip Osteoarthritis Pain Medicine Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Hip Osteoarthritis Pain Medicine Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Hip Osteoarthritis Pain Medicine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Hip Osteoarthritis Pain Medicine Covered in This Study Table 5. Global Hip Osteoarthritis Pain Medicine Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Manufacturers (2016-2021) Table 7. Global Hip Osteoarthritis Pain Medicine Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Hip Osteoarthritis Pain Medicine Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Hip Osteoarthritis Pain Medicine Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Hip Osteoarthritis Pain Medicine Manufacturing Sites and Area Served Table 11. Manufacturers Hip Osteoarthritis Pain Medicine Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Hip Osteoarthritis Pain Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hip Osteoarthritis Pain Medicine as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Hip Osteoarthritis Pain Medicine Sales by Region (2016-2021) & (K Units) Table 16. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Region (2016-2021) Table 17. Global Hip Osteoarthritis Pain Medicine Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Hip Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (K Units) Table 19. North America Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2016-2021) Table 20. North America Hip Osteoarthritis Pain Medicine Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2016-2021) Table 22. Europe Hip Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (K Units) Table 23. Europe Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2016-2021) Table 24. Europe Hip Osteoarthritis Pain Medicine Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Hip Osteoarthritis Pain Medicine Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Hip Osteoarthritis Pain Medicine Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Hip Osteoarthritis Pain Medicine Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Hip Osteoarthritis Pain Medicine Revenue Market Share by Region (2016-2021) Table 30. Latin America Hip Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (K Units) Table 31. Latin America Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2016-2021) Table 32. Latin America Hip Osteoarthritis Pain Medicine Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Hip Osteoarthritis Pain Medicine Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Hip Osteoarthritis Pain Medicine Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2016-2021) Table 38. Global Hip Osteoarthritis Pain Medicine Sales (K Units) by Type (2016-2021) Table 39. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2016-2021) Table 40. Global Hip Osteoarthritis Pain Medicine Revenue (Million US$) by Type (2016-2021) Table 41. Global Hip Osteoarthritis Pain Medicine Revenue Share by Type (2016-2021) Table 42. Global Hip Osteoarthritis Pain Medicine Price (USD/Unit) by Type (2016-2021) Table 43. Global Hip Osteoarthritis Pain Medicine Sales (K Units) by Application (2016-2021) Table 44. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2016-2021) Table 45. Global Hip Osteoarthritis Pain Medicine Revenue (Million US$) by Application (2016-2021) Table 46. Global Hip Osteoarthritis Pain Medicine Revenue Share by Application (2016-2021) Table 47. Global Hip Osteoarthritis Pain Medicine Price (USD/Unit) by Application (2016-2021) Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Pfizer Hip Osteoarthritis Pain Medicine Product Table 52. Pfizer Recent Developments/Updates Table 53. Johnson and Johnson Corporation Information Table 54. Johnson and Johnson Description and Business Overview Table 55. Johnson and Johnson Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Johnson and Johnson Hip Osteoarthritis Pain Medicine Product Table 57. Johnson and Johnson Recent Developments/Updates Table 58. GlaxoSmithKline Corporation Information Table 59. GlaxoSmithKline Description and Business Overview Table 60. GlaxoSmithKline Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. GlaxoSmithKline Hip Osteoarthritis Pain Medicine Product Table 62. GlaxoSmithKline Recent Developments/Updates Table 63. Bayer Corporation Information Table 64. Bayer Description and Business Overview Table 65. Bayer Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Bayer Hip Osteoarthritis Pain Medicine Product Table 67. Bayer Recent Developments/Updates Table 68. Eli Lilly Corporation Information Table 69. Eli Lilly Description and Business Overview Table 70. Eli Lilly Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Eli Lilly Hip Osteoarthritis Pain Medicine Product Table 72. Eli Lilly Recent Developments/Updates Table 73. Novartis Corporation Information Table 74. Novartis Description and Business Overview Table 75. Novartis Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Novartis Hip Osteoarthritis Pain Medicine Product Table 77. Novartis Recent Developments/Updates Table 78. Sanofi Corporation Information Table 79. Sanofi Description and Business Overview Table 80. Sanofi Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Sanofi Hip Osteoarthritis Pain Medicine Product Table 82. Sanofi Recent Developments/Updates Table 83. Horizon Pharma Corporation Information Table 84. Horizon Pharma Description and Business Overview Table 85. Horizon Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Horizon Pharma Hip Osteoarthritis Pain Medicine Product Table 87. Horizon Pharma Recent Developments/Updates Table 88. Abbott Corporation Information Table 89. Abbott Description and Business Overview Table 90. Abbott Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Abbott Hip Osteoarthritis Pain Medicine Product Table 92. Abbott Recent Developments/Updates Table 93. Mylan Corporation Information Table 94. Mylan Description and Business Overview Table 95. Mylan Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Mylan Hip Osteoarthritis Pain Medicine Product Table 97. Mylan Recent Developments/Updates Table 98. Daiichi Sankyo Corporation Information Table 99. Daiichi Sankyo Description and Business Overview Table 100. Daiichi Sankyo Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Daiichi Sankyo Hip Osteoarthritis Pain Medicine Product Table 102. Daiichi Sankyo Recent Developments/Updates Table 103. TEVA Corporation Information Table 104. TEVA Description and Business Overview Table 105. TEVA Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. TEVA Hip Osteoarthritis Pain Medicine Product Table 107. TEVA Recent Developments/Updates Table 108. Almatica Pharma Corporation Information Table 109. Almatica Pharma Description and Business Overview Table 110. Almatica Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 111. Almatica Pharma Hip Osteoarthritis Pain Medicine Product Table 112. Almatica Pharma Recent Developments/Updates Table 113. Astellas Pharma Corporation Information Table 114. Astellas Pharma Description and Business Overview Table 115. Astellas Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 116. Astellas Pharma Hip Osteoarthritis Pain Medicine Product Table 117. Astellas Pharma Recent Developments/Updates Table 118. Tide Pharmaceutical Corporation Information Table 119. Tide Pharmaceutical Description and Business Overview Table 120. Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 121. Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Product Table 122. Tide Pharmaceutical Recent Developments/Updates Table 123. Iroko Pharmaceuticals Corporation Information Table 124. Iroko Pharmaceuticals Description and Business Overview Table 125. Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 126. Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Product Table 127. Iroko Pharmaceuticals Recent Developments/Updates Table 128. Hengrui Pharmaceutical Corporation Information Table 129. Hengrui Pharmaceutical Description and Business Overview Table 130. Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 131. Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Product Table 132. Hengrui Pharmaceutical Recent Developments/Updates Table 133. Abiogen Pharma Corporation Information Table 134. Abiogen Pharma Description and Business Overview Table 135. Abiogen Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 136. Abiogen Pharma Hip Osteoarthritis Pain Medicine Product Table 137. Abiogen Pharma Recent Developments/Updates Table 138. Production Base and Market Concentration Rate of Raw Material Table 139. Key Suppliers of Raw Materials Table 140. Hip Osteoarthritis Pain Medicine Distributors List Table 141. Hip Osteoarthritis Pain Medicine Customers List Table 142. Hip Osteoarthritis Pain Medicine Market Trends Table 143. Hip Osteoarthritis Pain Medicine Growth Drivers Table 144. Hip Osteoarthritis Pain Medicine Market Challenges Table 145. Hip Osteoarthritis Pain Medicine Market Restraints Table 146. Global Hip Osteoarthritis Pain Medicine Sales Forecast by Type (2022-2027) & (K Units) Table 147. Global Hip Osteoarthritis Pain Medicine Sales Market Share Forecast by Type (2022-2027) Table 148. Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Type (2022-2027) & (US$ Million) Table 149. Global Hip Osteoarthritis Pain Medicine Revenue Market Share Forecast by Type (2022-2027) Table 150. Global Hip Osteoarthritis Pain Medicine Sales Forecast by Application (2022-2027) & (K Units) Table 151. Global Hip Osteoarthritis Pain Medicine Sales Market Share Forecast by Application (2022-2027) Table 152. Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 153. Global Hip Osteoarthritis Pain Medicine Revenue Market Share Forecast by Application (2022-2027) Table 154. Global Hip Osteoarthritis Pain Medicine Sales Forecast by Region (2022-2027) & (K Units) Table 155. Global Hip Osteoarthritis Pain Medicine Sales Market Share Forecast by Region (2022-2027) Table 156. Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 157. Global Hip Osteoarthritis Pain Medicine Revenue Market Share Forecast by Region (2022-2027) Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Hip Osteoarthritis Pain Medicine Figure 2. Global Hip Osteoarthritis Pain Medicine Market Share by Type in 2020 & 2027 Figure 3. Oral Product Picture Figure 4. Injection Product Picture Figure 5. External Product Picture Figure 6. Global Hip Osteoarthritis Pain Medicine Market Share by Application in 2020 & 2027 Figure 7. Medical Care Figure 8. Personal Care Figure 9. Global Hip Osteoarthritis Pain Medicine Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Hip Osteoarthritis Pain Medicine Market Size 2016-2027 (US$ Million) Figure 11. Global Hip Osteoarthritis Pain Medicine Sales 2016-2027 (K Units) Figure 12. Global Hip Osteoarthritis Pain Medicine Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Hip Osteoarthritis Pain Medicine Sales Share by Manufacturers in 2020 Figure 14. Global Hip Osteoarthritis Pain Medicine Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Hip Osteoarthritis Pain Medicine Players: Market Share by Revenue in 2020 Figure 16. Hip Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Region (2016-2021) Figure 18. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Region in 2020 Figure 19. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Region (2016-2021) Figure 20. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Region in 2020 Figure 21. U.S. Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. UAE Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Hip Osteoarthritis Pain Medicine by Type (2016-2021) Figure 46. Sales Market Share of Hip Osteoarthritis Pain Medicine by Application (2016-2021) Figure 47. Sales Market Share of Hip Osteoarthritis Pain Medicine by Application in 2020 Figure 48. Revenue Share of Hip Osteoarthritis Pain Medicine by Application (2016-2021) Figure 49. Revenue Share of Hip Osteoarthritis Pain Medicine by Application in 2020 Figure 50. Manufacturing Cost Structure of Hip Osteoarthritis Pain Medicine Figure 51. Manufacturing Process Analysis of Hip Osteoarthritis Pain Medicine Figure 52. Hip Osteoarthritis Pain Medicine Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Pfizer Johnson and Johnson GlaxoSmithKline Bayer Eli Lilly Novartis Sanofi Horizon Pharma Abbott Mylan Daiichi Sankyo TEVA Almatica Pharma Astellas Pharma Tide Pharmaceutical Iroko Pharmaceuticals Hengrui Pharmaceutical Abiogen Pharma